Сравнение методов

	Байесовский анализ обогащения генных наборов	Анализ дифференциальной экспрессии РНК-сек (DE)
Область	Биоинформатика	Биоинформатика
Семейство	Process / pipeline	Process / pipeline
Год появления	2004–2007	2008–2010 (RNA-seq DE methodology established)
Автор метода	Michael A. Newton, Frank A. Quintana and colleagues; building on Subramanian et al. GSEA framework	Multiple groups; foundational methods from Anders & Huber (DESeq, 2010), Robinson, McCarthy & Smyth (edgeR, 2010)
Тип	Probabilistic gene set enrichment method	Quantitative genomics pipeline
Основополагающий источник	Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., ... & Mesirov, J. P. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545-15550.	Love, M. I., Huber, W., & Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15(12), 550.
Другие названия	Bayesian GSEA, BGSEA, Bayesian pathway scoring, probabilistic gene set testing	RNA-seq DE analysis, transcriptomic differential expression, bulk RNA-seq DE, DEA
Связанные	6	6
Сводка	Bayesian gene set enrichment analysis (Bayesian GSEA) applies a probabilistic framework to determine whether predefined sets of genes — representing biological pathways, cellular processes, or functional categories — are collectively more differentially expressed than expected by chance. Unlike classical frequentist GSEA, the Bayesian approach models uncertainty in expression estimates explicitly, incorporates prior biological knowledge, and produces posterior probabilities of enrichment rather than raw p-values, enabling more principled inference especially in small-sample settings.	RNA-seq differential expression (DE) analysis identifies genes whose transcript abundance differs significantly between two or more biological conditions — for example, treated versus control, or diseased versus healthy tissue. Starting from raw sequencing reads, the pipeline moves through alignment, count-based normalization, statistical modeling of count dispersion, hypothesis testing, and multiple-testing correction to produce a ranked list of differentially expressed genes accompanied by fold-change estimates and adjusted p-values.